Delivery Order SPE2DB20D3103-SPE2DB25FP6E9
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Lidocaine 5% Patch 30s, with a ceiling value of $17,680.85. This firm fixed-price delivery order represents a competitive award with no set-aside designation and is scheduled for completion by July 23, 2025. The product will be supplied from AmerisourceBergen's location in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters. This delivery order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Lidocaine 5% Patch in quantities of 30 units. This contract is a firm fixed price delivery order with a ceiling value of $7,341.46 and an ultimate completion date of September 18, 2025. The work will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This award represents a non-set-aside competitive procurement action under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Lidocaine 5% Patch 30-count units, with a ceiling value of $10,232.40. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The contract involves no set-aside designation...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Lidocaine 5% Patch 30s, with a ceiling value of $7,204.35. This firm fixed price delivery order represents a non-competitive set-aside award and is scheduled for ultimate completion on July 24, 2025. The product will be delivered to the company's headquarters location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for Lidocaine 5% Patch in quantities of 30 units, with a ceiling value of $10,360.64. This firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The award carries an ultimate completion date of August 11, 2025,...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $1,361.04 by the Defense Logistics Agency (DLA) on August 15, 2025, for the supply of Lidocaine 5% Patch 30s. The contract employs firm fixed-price pricing with a completion deadline of August 18, 2025, and was awarded through open competition with no set-aside designation. This delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 17, 2025, for Lidocaine 5% Patch 30-count units with a ceiling value of $3,936.42. This is a firm fixed price, non-competitive delivery order with an ultimate completion date of June 18, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs, particularly for military and veteran healthcare systems. The order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Lidocaine 5% Patch 30s under a firm fixed-price contract with a ceiling value of $3,380.41. This non-set-aside delivery order was awarded on August 1, 2025, with an ultimate completion date of August 4, 2025. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office. This delivery order represents a child contract action under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $3,576.20 to AmerisourceBergen Drug Corp for Lidocaine 5% Patch 30s on September 19, 2025, with an ultimate completion date of September 22, 2025. The contract is a firm fixed price delivery order with no set-aside designation, competitively awarded to the Conshohocken, Pennsylvania-based pharmaceutical distributor. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $14,370.05 on August 4, 2025, for the supply of Lidocaine 5% Patch 30S, with an ultimate completion date of August 5, 2025. This non-set-aside contract utilizes firm fixed price pricing and will be performed at the company's corporate office in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB25FP6E9Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Lidocaine 5% patches in a quantity of 30 units, with a ceiling value of $2,722.08. This firm fixed-price delivery order, which is not set-aside, is scheduled for completion by July 25, 2025, and will be performed at AmerisourceBergen's Conshohocken, Pennsylvania facility. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.9 billion prime vehicle that runs through December 2026 and serves as the company's comprehensive global pharmaceutical support mechanism for military healthcare programs. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, has established itself as a critical federal vendor through its extensive portfolio of medical product deliveries to the Defense Logistics Agency and other government healthcare systems. The company's federal contracting history demonstrates competitive capability across a wide spectrum of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, and medical devices serving military and veteran healthcare needs. The Lidocaine patch delivery order reflects the routine pharmaceutical procurement operations conducted through the company's DLA relationship, supporting ongoing medical supply requirements across federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.7k | 7/24/25 |